{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:32:24Z","timestamp":1759411944380,"version":"3.40.5"},"reference-count":24,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:p>Objective. To evaluate current performance on recommended perinatal hepatitis B and rubella prevention practices in New Hampshire.<\/jats:p>\n               <jats:p>Methods. Data were extracted from 2021 paired mother-infant records for the year 2000 birth cohort in New Hampshire's 25 delivery hospitals. Assessment was done on the following: prenatal screening for hepatitis B and rubella, administration of the hepatitis B vaccine birth dose to all infants, administration of hepatitis B immune globulin to infants who were born to hepatitis B surface antigen-positive mothers, rubella immunity, and administration of in-hospital postpartum rubella vaccine to rubella nonimmune women.<\/jats:p>\n               <jats:p>Results. Prenatal screening rates for hepatitis B (98.8%) and rubella (99.4%) were high. Hepatitis B vaccine birth dose was administered to 76.2% of all infants. All infants who were born to hepatitis B surface antigen-positive mothers also received hepatitis B immune globulin. Multivariate logistic regression showed that the month of delivery and infant birth weight were independent predictors of hepatitis B vaccination. The proportion of infants who were vaccinated in January and February 2000 (48.5% and 67.5%, respectively) was less than any other months, whereas the proportion who were vaccinated in December 2000 (88.2%) was the highest. Women who were born between 1971 and 1975 had the highest rate of rubella nonimmunity (9.5%). In-hospital postpartum rubella vaccine administration was documented for 75.6% of nonimmune women.<\/jats:p>\n               <jats:p>Conclusion. This study documents good compliance in New Hampshire's birthing hospitals with national guidelines for perinatal hepatitis B and rubella prevention and highlights potential areas for improvement.<\/jats:p>","DOI":"10.1542\/peds.2004-2057","type":"journal-article","created":{"date-parts":[[2005,5,2]],"date-time":"2005-05-02T19:38:07Z","timestamp":1115062687000},"page":"e594-e599","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of Perinatal Hepatitis B and Rubella Prevention in New Hampshire Delivery Hospitals"],"prefix":"10.1542","volume":"115","author":[{"given":"Susan","family":"Bascom","sequence":"first","affiliation":[{"name":"From the New Hampshire Department of Health and Human Services, Division of Public Health Services, Concord, New Hampshire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Miller","sequence":"additional","affiliation":[{"name":"From the New Hampshire Department of Health and Human Services, Division of Public Health Services, Concord, New Hampshire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Greenblatt","sequence":"additional","affiliation":[{"name":"From the New Hampshire Department of Health and Human Services, Division of Public Health Services, Concord, New Hampshire"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,5,1]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Bath SK, Singleton JA, Strikas RA, Stevenson JM, McDonald LL, Williams WW. Performance of US hospitals on recommended screening and immunization practices for pregnant and postpartum women. Am J Infect Control.\u20082000;28:327\u2013332","key":"2021120819244688900_R1","DOI":"10.1067\/mic.2000.109886"},{"unstructured":"Atkinson W, Wolfe C, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 7th ed. Atlanta, GA: National Immunization Program, Centers for Disease Control and Prevention; 2002:169\u2013189","key":"2021120819244688900_R2"},{"doi-asserted-by":"crossref","unstructured":"McMahon BJ, Alward WLM, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis.\u20081985;151:599\u2013603","key":"2021120819244688900_R3","DOI":"10.1093\/infdis\/151.4.599"},{"unstructured":"Centers for Disease Control and Prevention. Hepatitis Surveillance Report. No. 56. Atlanta, GA: CDC; 1996","key":"2021120819244688900_R4"},{"unstructured":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep.\u20081991;40:1\u201325","key":"2021120819244688900_R5"},{"unstructured":"Centers for Disease Control and Prevention. Recommendations of the Immunization Practices Advisory Committee prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR.\u20081988;37:341\u2013346, 351","key":"2021120819244688900_R6"},{"unstructured":"Centers for Disease Control and Prevention. Recommendations of the Immunization Practices Advisory Committee (ACIP): Rubella prevention. MMWR Morb Mortal Wkly Rep.\u20081981;30:37\u201342,47","key":"2021120819244688900_R7"},{"unstructured":"Atkinson W, Wolfe C, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 7th ed. Atlanta, GA: National Immunization Program, Centers for Disease Control and Prevention; 2002:124\u2013138","key":"2021120819244688900_R8"},{"doi-asserted-by":"crossref","unstructured":"Orenstein WA, Bart KJ, Hinman AR, et al. The opportunity and obligation to eliminate rubella from the United States. JAMA.\u20081984;251:1988\u20131994","key":"2021120819244688900_R9","DOI":"10.1001\/jama.251.15.1988"},{"unstructured":"Healthy people 2010. Conference ed., vol 1, objective 14-1i:14\u201311. Washington, DC: US Department of Health and Human Services; January 2000. Available at: www.health.gov\/healthypeople\/document\/html\/volume1\/14immunization.htm","key":"2021120819244688900_R10"},{"doi-asserted-by":"crossref","unstructured":"Dykewicz CA, Kruszon-Moran D, McQuillan GM, et al. Rubella seropositivity in the United States, 1988\u20131994. Clin Infect Dis.\u20082001;33:1279\u20131286","key":"2021120819244688900_R11","DOI":"10.1086\/322651"},{"unstructured":"Wexler DL. Give the birth dose\u2026hepatitis B vaccine at birth saves lives! 2002. Available at: www.immunize.org\/catg.d\/p2125.pdf. Accessed March 18, 2005","key":"2021120819244688900_R12"},{"doi-asserted-by":"crossref","unstructured":"Yusuf HR, Daniels D, Smith P, Coronado V, Rodewald L. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. JAMA.\u20082000;284:978\u2013983","key":"2021120819244688900_R13","DOI":"10.1001\/jama.284.8.978"},{"unstructured":"Centers for Disease Control and Prevention. Notice to readers: recommended childhood immunization schedule\u2014United States, 2002. MMWR Morb Mortal Wkly Rep.\u20082002;51:31\u201333","key":"2021120819244688900_R14"},{"unstructured":"Centers for Disease Control and Prevention. Notice to readers: thimerosal in vaccine: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep.\u20081999;48:563\u2013565","key":"2021120819244688900_R15"},{"unstructured":"Centers for Disease Control and Prevention. Notice to readers: availability of hepatitis B vaccine that does not contain thimerosal as a preservative. MMWR Morb Mortal Wkly Rep.\u20081999;48:780\u2013782","key":"2021120819244688900_R16"},{"doi-asserted-by":"crossref","unstructured":"Hurie MB, Saari TN, Davis JP. Impact of the joint statement by the American Academy of Pediatrics\/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices. Pediatrics.\u20082001;107:755\u2013758","key":"2021120819244688900_R17","DOI":"10.1542\/peds.107.4.755"},{"doi-asserted-by":"crossref","unstructured":"Oram RJ, Daum RS, Seal JB, Lauderdale DS. Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine. JAMA.\u20082001;285:1874\u20131879","key":"2021120819244688900_R18","DOI":"10.1001\/jama.285.14.1874"},{"doi-asserted-by":"crossref","unstructured":"Clark SJ, Cabana MD, Malik T, Yusuf H, Freed GL. Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations. Arch Pediatr Adolesc Med.\u20082001;155:915\u2013920","key":"2021120819244688900_R19","DOI":"10.1001\/archpedi.155.8.915"},{"doi-asserted-by":"crossref","unstructured":"Schrag SJ, Arnold KE, Mohle-Boetani JC, et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol.\u20082003;102:753\u2013760","key":"2021120819244688900_R20","DOI":"10.1097\/00006250-200310000-00017"},{"unstructured":"Centers for Disease Control and Prevention. Rubella and congenital rubella syndrome\u2014United States, 1994\u20131997. MMWR Morb Mortal Wkly Rep.\u20081997;46:350\u2013354","key":"2021120819244688900_R21"},{"unstructured":"Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Morb Mortal Wkly Rep.\u20082001;50:1\u201323","key":"2021120819244688900_R22"},{"unstructured":"Simpson DM. Forty years and four surveys: how does our measuring measure up?Am J Prev Med.\u20082001;20(suppl):6\u201314","key":"2021120819244688900_R23"},{"doi-asserted-by":"crossref","unstructured":"Cheldelin LAV, Francis DP, Tilson H. Postpartum rubella vaccination. A survey of private physicians in Oregon. JAMA.\u20081973;225:158\u2013159","key":"2021120819244688900_R24","DOI":"10.1001\/jama.225.2.158"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/5\/e594\/1029018\/zpe0050500e594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/5\/e594\/1029018\/zpe0050500e594.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T20:37:35Z","timestamp":1638995855000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/115\/5\/e594\/67510\/Assessment-of-Perinatal-Hepatitis-B-and-Rubella"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,5,1]]},"published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2057","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}